FDA questions safety of Glaxo kidney cancer drug
Thursday, October 1, 2009 - 12:14
in Health & Medicine
(AP) -- Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.